Neel Parekh, MD
Payments from drug & device makers
Across 546 payments — averaging $244.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Antares Pharma, Inc.$103K
- Boston Scientific$20K
- Coloplast$3K
- Olympus America Inc.$1K
- Procept Biorobotics Corporation$654
- Endo Pharmaceuticals Inc.$544
- plus $4K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Antares Pharma, Inc. | 106 | $103,226 |
| Boston Scientific | 283 | $20,379 |
| Coloplast | 33 | $2,980 |
| Olympus America Inc. | 21 | $1,427 |
| Procept Biorobotics Corporation | 6 | $654 |
| Endo Pharmaceuticals Inc. | 25 | $544 |
| Biotissue Holdings Inc. | 6 | $519 |
| Astellas Pharma US Inc | 6 | $396 |
| Teleflex LLC | 4 | $394 |
| Sumitomo Pharma America, Inc. | 8 | $289 |
| Neotract Inc. | 3 | $250 |
| EDAP Technomed Inc | 1 | $248 |
| Tolmar, Inc. | 11 | $241 |
| Halozyme Inc | 5 | $220 |
| Aroa Biosurgery Incorporated | 2 | $189 |
| Endo USA, Inc. | 6 | $187 |
| Urogen Pharma, Inc. | 5 | $179 |
| Calyxo, Inc. | 3 | $174 |
| Dornier Medtech America, Inc | 1 | $157 |
| Kerecis Limited | 1 | $124 |
| Myovant Sciences Inc. | 1 | $119 |
| Bard Access Systems, Inc. | 1 | $100 |
| Cook Medical LLC | 1 | $96 |
| Photocure Inc | 1 | $65 |
| Caldera Medical, Inc | 1 | $65 |
| Progenics Pharmaceuticals, Inc. | 1 | $64 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $30 |
| Pharmaand GmbH | 1 | $22 |
| Johnson & Johnson | 1 | $14 |
| Medtronic | 1 | $14 |
How this compares
$133,366 in reported general payments places this provider in the 90th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Akron
- Marc PliskinCincinnati$20.8M
- Lawrence GervasiMiddleburg Heights$4.7M
- Martin FritzhandCincinnati$4.6M
- Kamal PoharCincinnati$3.4M
- Eric SingerColumbus$2.1M
- Benjamin MartinGahanna$1.1M
- Howard GoldmanCleveland$747K
- Jihad KaoukCleveland$696K
- Raymond RackleyCleveland$695K
- Sandip VasavadaCleveland$512K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.